KLEA HOLDING
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. The company was formerly known as Visiom… Read more
KLEA HOLDING - Asset Resilience Ratio
KLEA HOLDING (ALKLH) has an Asset Resilience Ratio of 79.75% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2021)
This chart shows how KLEA HOLDING's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down KLEA HOLDING's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €27.44 Million | 79.75% |
| Total Liquid Assets | €27.44 Million | 79.75% |
Asset Resilience Insights
- Very High Liquidity: KLEA HOLDING maintains exceptional liquid asset reserves at 79.75% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
KLEA HOLDING Industry Peers by Asset Resilience Ratio
Compare KLEA HOLDING's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for KLEA HOLDING (2010–2021)
The table below shows the annual Asset Resilience Ratio data for KLEA HOLDING.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.02% | €7.00K | €44.07 Million | -0.51pp |
| 2020-12-31 | 0.52% | €31.00K | €5.91 Million | -2.29pp |
| 2019-12-31 | 2.82% | €415.00K | €14.73 Million | +0.58pp |
| 2018-12-31 | 2.24% | €415.00K | €18.52 Million | -0.23pp |
| 2017-12-31 | 2.47% | €497.75K | €20.14 Million | -1.56pp |
| 2016-12-31 | 4.03% | €782.21K | €19.41 Million | -0.39pp |
| 2015-12-31 | 4.42% | €851.67K | €19.27 Million | -1.50pp |
| 2014-12-31 | 5.92% | €889.10K | €15.01 Million | -0.45pp |
| 2013-12-31 | 6.37% | €803.74K | €12.62 Million | +0.37pp |
| 2012-12-31 | 6.00% | €774.97K | €12.91 Million | +0.70pp |
| 2011-12-31 | 5.30% | €818.33K | €15.43 Million | +3.02pp |
| 2010-12-31 | 2.29% | €300.00K | €13.11 Million | -- |